Mad in America
FEBRUARY 10, 2024
Multiple studies have found that even for severe depression, adding antidepressants to cognitive behavioral therapy does not result in better outcomes —psychotherapy alone is just as good in the short term. And therapy alone beats the drugs when it comes to long-term outcomes.
Mad in America
FEBRUARY 7, 2024
Beyond “Diagnose and Prescribe” Rigid adherence to the model of “investigate, diagnose, prescribe” limits patients’ treatment options to those that are mainly pharmaceutical. Further, some doctors balk at the idea that anything but medication can be helpful to patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
OCTOBER 31, 2023
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. Remote therapy via the internet became routine during the COVID-19 epidemic. But it may still be too expensive for many people.
Mad in America
JANUARY 6, 2024
She introduced some techniques from cognitive behavioral therapy (CBT), an approach that focuses on helping patients identify irrational thoughts and assumptions and assembling evidence against them. New therapies are often referred to by initials—e.g.,
Mad in America
FEBRUARY 5, 2024
When antidepressants fail bring on cognitive behavioral therapy (CBT). In this blog, he addresses antidepressants versus CBT, the buzz around ketamine and esketamine, and the new frontier of drugs for postpartum depression. Each Monday, a new section of the book is published, and all chapters are archived here.
Expert insights. Personalized for you.
145 
Let's personalize your content